OTSUKA PHARMACEUTICAL CO., LTD. et al v. ACCORD HEALTHCARE INC. et al > Summary
Court Case Number 1:20-cv-00878
Filing Date Sep 24, 2020
Termination Date Feb 19, 2021
Court North Carolina Middle District Court
Status Dismissed - Voluntarily
Plaintiff Attorneys
7Otsuka Pharmaceutical
Attorney Name: Allison Mullins
Turning Point Litigation Mullins Duncan Harrell & Russell
Otsuka Pharmaceutical
Attorney Name: Stephen M. Russell Jr.
Turning Point Litigation Mullins Duncan Harrell & Russell
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Erin M. Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE048059 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jun 23, 2020 |
| 07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |
